annual working capital:
$499.51M-$23.27M(-4.45%)Summary
- As of today (September 16, 2025), SNDX annual working capital is $499.51 million, with the most recent change of -$23.27 million (-4.45%) on December 31, 2024.
- During the last 3 years, SNDX annual working capital has risen by +$71.80 million (+16.79%).
- SNDX annual working capital is now -4.45% below its all-time high of $522.78 million, reached on December 31, 2023.
Performance
SNDX Working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly working capital:
$418.69M-$35.51M(-7.82%)Summary
- As of today (September 16, 2025), SNDX quarterly working capital is $418.69 million, with the most recent change of -$35.51 million (-7.82%) on June 30, 2025.
- Over the past year, SNDX quarterly working capital has increased by +$15.11 million (+3.74%).
- SNDX quarterly working capital is now -19.91% below its all-time high of $522.78 million, reached on December 31, 2023.
Performance
SNDX quarterly working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Working capital Formula
Working Capital = Current Assets − Current Liabilities
SNDX Working capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -4.5% | +3.7% |
| 3 y3 years | +16.8% | +15.9% |
| 5 y5 years | +1036.2% | +133.5% |
SNDX Working capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -4.5% | +16.8% | -19.9% | +24.3% |
| 5 y | 5-year | -4.5% | +1036.2% | -19.9% | +158.0% |
| alltime | all time | -4.5% | +2149.8% | -19.9% | +9084.7% |
SNDX Working capital History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $418.69M(-7.8%) |
| Mar 2025 | - | $454.20M(-9.1%) |
| Dec 2024 | $499.51M(-4.5%) | $499.51M(+40.5%) |
| Sep 2024 | - | $355.43M(-11.9%) |
| Jun 2024 | - | $403.58M(+0.1%) |
| Mar 2024 | - | $403.09M(-22.9%) |
| Dec 2023 | $522.78M(+13.5%) | $522.78M(+52.9%) |
| Sep 2023 | - | $341.80M(-9.8%) |
| Jun 2023 | - | $378.91M(-9.3%) |
| Mar 2023 | - | $417.79M(-9.3%) |
| Dec 2022 | $460.72M(+7.7%) | $460.72M(+36.8%) |
| Sep 2022 | - | $336.83M(-6.8%) |
| Jun 2022 | - | $361.36M(-7.2%) |
| Mar 2022 | - | $389.50M(-8.9%) |
| Dec 2021 | $427.71M(+52.8%) | $427.71M(+104.1%) |
| Sep 2021 | - | $209.54M(-12.1%) |
| Jun 2021 | - | $238.26M(-6.3%) |
| Mar 2021 | - | $254.38M(-9.1%) |
| Dec 2020 | $279.99M(+536.9%) | $279.99M(+72.5%) |
| Sep 2020 | - | $162.28M(-9.5%) |
| Jun 2020 | - | $179.34M(+110.0%) |
| Mar 2020 | - | $85.42M(+94.3%) |
| Dec 2019 | $43.96M | $43.96M(-22.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $56.56M(-17.2%) |
| Jun 2019 | - | $68.28M(-16.7%) |
| Mar 2019 | - | $81.97M(+21.9%) |
| Dec 2018 | $67.24M(-42.8%) | $67.24M(-14.7%) |
| Sep 2018 | - | $78.83M(-7.7%) |
| Jun 2018 | - | $85.40M(-16.6%) |
| Mar 2018 | - | $102.40M(-13.0%) |
| Dec 2017 | $117.64M(+19.9%) | $117.64M(+7.2%) |
| Sep 2017 | - | $109.76M(-10.5%) |
| Jun 2017 | - | $122.66M(+42.5%) |
| Mar 2017 | - | $86.07M(-12.3%) |
| Dec 2016 | $98.14M(+18.0%) | $98.14M(-9.2%) |
| Sep 2016 | - | $108.12M(-10.5%) |
| Jun 2016 | - | $120.83M(-6.1%) |
| Mar 2016 | - | $128.73M(+5606.2%) |
| Dec 2015 | $83.16M(+3863.8%) | - |
| Dec 2014 | $2.10M(-82.2%) | - |
| Sep 2014 | - | $2.26M(+310.9%) |
| Jun 2014 | - | $549.00K(-92.8%) |
| Mar 2014 | - | $7.67M(-35.1%) |
| Dec 2013 | $11.81M(-148.5%) | $11.81M(-353.5%) |
| Sep 2013 | - | -$4.66M |
| Dec 2012 | -$24.37M(+170.3%) | - |
| Dec 2011 | -$9.02M | - |
FAQ
- What is Syndax Pharmaceuticals, Inc. annual working capital?
- What is the all time high annual working capital for Syndax Pharmaceuticals, Inc.?
- What is Syndax Pharmaceuticals, Inc. annual working capital year-on-year change?
- What is Syndax Pharmaceuticals, Inc. quarterly working capital?
- What is the all time high quarterly working capital for Syndax Pharmaceuticals, Inc.?
- What is Syndax Pharmaceuticals, Inc. quarterly working capital year-on-year change?
What is Syndax Pharmaceuticals, Inc. annual working capital?
The current annual working capital of SNDX is $499.51M
What is the all time high annual working capital for Syndax Pharmaceuticals, Inc.?
Syndax Pharmaceuticals, Inc. all-time high annual working capital is $522.78M
What is Syndax Pharmaceuticals, Inc. annual working capital year-on-year change?
Over the past year, SNDX annual working capital has changed by -$23.27M (-4.45%)
What is Syndax Pharmaceuticals, Inc. quarterly working capital?
The current quarterly working capital of SNDX is $418.69M
What is the all time high quarterly working capital for Syndax Pharmaceuticals, Inc.?
Syndax Pharmaceuticals, Inc. all-time high quarterly working capital is $522.78M
What is Syndax Pharmaceuticals, Inc. quarterly working capital year-on-year change?
Over the past year, SNDX quarterly working capital has changed by +$15.11M (+3.74%)